We appreciate your interest in the Alzheimer’s Disease Data Initiative. Visit us at Booth #04 anytime throughout the conference!

Featured Sessions and Events:

Alzheimer's Insights Summit 3
Tuesday, March 17  |  8:30 AM – 3:30 PM CET  |  Hall A2

• Co-convened with the Alzheimer’s Drug Discovery Foundation, the summit will feature engaging discussions from trailblazers, product launches, a networking lunch, and the final pitch competition for the $1 million Alzheimer's Insights AI Prize.
• Contact PrecisionMedComms-ADDF@precisionaq.com to request an invitation to attend

Global Neurodegeneration Proteomics Consortium (GNPC): Research based on the largest disease-specific proteomics dataset in the world, built on AD Workbench
Tuesday, March 17  |  9:45 – 10:00a CET  |  Concurrent Sessions

• Lijun An, Oral Presentation: Benchmarking the AI-based diagnostic potential of plasma proteomics for neurodegenerative disease in 17,187 people. Location: Auditorium 12
• Fiona Xu, Oral Presentation: CSF and plasma protein classifier for predicting disease-specific and multiple dementia types (AD and PD) by multiple AI-based models. Location: Hall A3

Fireside Debate: Industry Meets Academia: Moonshots and Milestones: Is the Future of Neurodegeneration Drug Discovery in Startups, Foundations, Big Pharma, Or Academia?
Tuesday, March 17  |  5:00 PM – 6:00 PM CET  |  Hall A1

• Hear from AD Data Initiative Interim Executive Director Niranjan Bose in this AD/PD session bringing together voices from across the drug discovery ecosystem to debate where the most promising advances in neurodegeneration research are really coming from. 

Forum 02: Beyond One Size Fits All: Precision Drug Development, AI Methods, and Trial Design in AD/PD
Wednesday, March 18  |  3:35 – 4:35 PM CET  |  Hall A1

• Join this forum diving into the future of precision drug development, featuring AD Data Initiative Senior Advisor Greg Moore.

Find our Fellows:

The William H. Gates, Sr. Fellows: Cohort II Research Discussions
Wednesday, March 18  |  5:00 – 7:00 PM CET | Hall A2

• Kimberley Billingsley, Oral Presentation: Population-Scale Long-Read Sequencing to Advance the Genetics and Epigenetics of Neurodegenerative Disease

Posters

• Tavia Evans, Poster: Exploring the Potential of CT in Subcortical Volume Analysis for Dementia Research
  Poster on Board Shift 01 - Board #362 | Abstract Submission #1144
• Liz Lee, Poster: Multimodal AI Modelling for Biomarker Integration: Leveraging Omics and Blood-Based Markers for Early AD Prediction
  Poster on Board Shift 02 - Board #330 | Abstract Submission #755